Blog

July 20, 2022

This is a guest post by John Lumpkin, M.D., President of the Blue Cross and Blue Shield of North Carolina Foundation and Vice President, Drivers of Health. Blue Cross and … Continued

June 27, 2022

Vaccines are integral to preventing diseases and reducing the chance of illness for individuals. They significantly lower the risk of severe illness and hospitalization, and even death, as well as … Continued

June 1, 2022

Across the healthcare industry work is taking place to address health disparities. The Healthcare Leadership Council (HLC) has delved specifically into social determinants of health, broadband access, disparities in care … Continued

May 25, 2022

Recently, Health Affairs Forefront, published a post by Dan L. Crippen, former director of the Congressional Budget Office and currently a Healthcare Leaddership Council consultant, that should be a catalyst … Continued

May 4, 2022

So much of the nation’s discussion about the Medicare-for-all concept takes place through a political prism.  It’s important, though, to fully understand what such a drastic change to our healthcare … Continued

April 14, 2022

I was pleased to provide a summary of Surescripts’ interoperability panel in Orlando for the Intelligence in Action blog. I have provided a copy below, without the accompanying graphics. You … Continued

February 8, 2022

The HIMSS Global Health Conference & Exhibition is approaching quickly. This year it takes place March 14-18 in Orlando, Florida. A price increase will go into effect on February 14, … Continued

November 30, 2021

Now decades into the digital age, most tasks can be completed electronically – ordering food, booking appointments, transferring funds, and even signing contracts. In the healthcare world, medical records and … Continued

October 28, 2021

Guest post by: Dana Dornsife, Founder and CEO, Lazarex Cancer Foundation There are many avenues to addressing health disparities, an essential health policy objective. To determine the most appropriate strategies, … Continued

October 15, 2021

An important development in the biopharmaceutical world, with significant ramifications for patients, is the progress being made on biosimilars.  These are products with the same safety and efficacy as FDA-approved … Continued